Pyridostigmine - Isotope Labelled Standards
References
FAQ's
References
- Yakatan, Gerald J.; Tien, Jy-Yean, Quantitation of pyridostigmine in plasma using high-performance liquid chromatography, Journal of Chromatography, Biomedical Applications,Volume: 164 Issue: 3, Pages: 399-403,1979
- Coper, H.; Deyhle, G.; Dross, K., Absorption of pyridostigmine. Application of a spectrophotometric method for the determination of pyridostigmine in plasma, Zeitschrift fuer Klinische Chemie und Klinische Biochemie, Volume: 12, Issue: 6, Pages: 273-5, 1974
Frequently Asked Questions
Are the levels of Pyridostigmine impurities strictly regulated?
Yes, the levels of Pyridostigmine impurities are typically regulated to ensure the quality and safety of the drug.
What are the steps to remove Pyridostigmine impurities during the synthesis process?
During the synthetic process of Pyridostigmine, impurities are removed through purification methods such as crystallization, chromatography, or recrystallization.
What are the measures to ensure the safety and quality of Pyridostigmine impurities?
Rigorous testing and analysis are conducted throughout the manufacturing process, utilizing methods such as chromatography and spectroscopy to ensure the safety and quality of Pyridostigmine impurities and accurately identify, quantify, and control impurities within acceptable limits set by regulatory authorities.
What are the temperature conditions required to store Pyridostigmine impurities?
Pyridostigmine impurities are stored preferably at a regulated room temperature of 2-8°C or as specified on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.